172 related articles for article (PubMed ID: 26973204)
1. Metformin use and survival from lung cancer: A population-based cohort study.
Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
3. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
[TBL] [Abstract][Full Text] [Related]
4. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
5. Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.
Lin J; Gill A; Zahm SH; Carter CA; Shriver CD; Nations JA; Anderson WF; McGlynn KA; Zhu K
Int J Cancer; 2017 Jul; 141(2):254-263. PubMed ID: 28380674
[TBL] [Abstract][Full Text] [Related]
6. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
7. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
Spillane S; Bennett K; Sharp L; Barron TI
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
[TBL] [Abstract][Full Text] [Related]
10. Statin use and survival from lung cancer: a population-based cohort study.
Cardwell CR; Mc Menamin Ú; Hughes CM; Murray LJ
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):833-41. PubMed ID: 25934831
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin and survival from lung cancer: a population-based cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
BMC Cancer; 2015 Nov; 15():911. PubMed ID: 26573580
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and lung cancer risk in patients with diabetes.
Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA
Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512
[TBL] [Abstract][Full Text] [Related]
13. Metformin does not alter the risk of lung cancer: a case-control analysis.
Bodmer M; Becker C; Jick SS; Meier CR
Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
[TBL] [Abstract][Full Text] [Related]
14. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
15. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
16. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
[TBL] [Abstract][Full Text] [Related]
18. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract][Full Text] [Related]
19. Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Mc Menamin ÚC; Hughes CM; Cardwell CR
Breast Cancer Res Treat; 2015 Jun; 151(3):661-9. PubMed ID: 25975954
[TBL] [Abstract][Full Text] [Related]
20. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
